- Sales grew 4%, but adj. EBITA margin down to 6.8% (7.
- Marginal estimate changes - Awaiting B2C and B2B volume recovery for growth upside - EV/ARR ~2.
Redeye’s view on the Q2 report. The organic growth was decent, while the gross margin development co...
Redeye provides a first take on Advenica’s second quarter of the year.
Redeye concludes that Q2 numbers on Group level were very much in-line with our expectations.
- Sales -14% vs. ABGSCe, EBIT SEK 0m vs. ABGSCe 2m - NW&FT drives sales miss due to restaurant marke...
Innofactor’s Q2 profitability was weak, although mostly due to one-offs.
Consti's net sales in Q2 amounted to EUR 82.9m, above our estimates (Evli est.
- Return to growth in Q2 bodes well for 9-10% organic growth in H2e - AI and cybersecurity among the...
Redeye comments on Annexin's Q2 report and recent events in the company.
Redeye sees a soft quarter from CombinedX, with slightly lower sales and substantially lower margins...
Redeye believes Sdiptech's Q2 report was solid, with continued good organic sales growth in both bus...
Redeye thinks the Q2 report was slightly better than expected - being in line with consensus estimat...
Redeye’s first take on the Q2 report this morning. Despite some underlying differences, Cellavision ...
- Rec. PTP +9% vs. ABGSCe - Value changes positive, first time since Q4'22 - Earnings capacity IFPM ...
